An announcement from Pharma Mar SA ( (ES:PHM) ) is now available.
Pharma Mar SA has reported on its recent share buy-back program activities conducted between April 14 and April 17, 2025. The company purchased a total of 1,600 shares at the BME trading center, with weighted average prices ranging from 75.00000 to 75.62000 per share, as part of its ongoing efforts to stabilize and manage its treasury stock.
More about Pharma Mar SA
Pharma Mar SA operates in the biotechnology industry, focusing on the development and commercialization of innovative marine-derived drugs for cancer treatment. The company is known for its pioneering work in oncology, leveraging its expertise in marine biology.
YTD Price Performance: 4.17%
Average Trading Volume: 1,304
Technical Sentiment Signal: Sell
Current Market Cap: $1.53B
For a thorough assessment of PHM stock, go to TipRanks’ Stock Analysis page.